Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11150

Apple’s first paper on artificial intelligence, published Dec. 22 on arXiv (open access), describes a method for improving the ability of a deep neural network to recognize images.

To train neural networks to recognize images, AI researchers have typically labeled (identified or described) each image in a dataset. For example, last year, Georgia Institute of Technology researchers developed a deep-learning method to recognize images taken at regular intervals on a person’s wearable smartphone camera.

Example images from dataset of 40,000 egocentric images with their respective labels (credit: Daniel Castro et al./Georgia Institute of Technology)

Read more

Some research suggests macrophages might be the best target for senescent cell therapies. Here is Mantas from cell age answering a reader question “Are senescent macrophages the problem of other cell types?”

Mantas from CellAge answers a question from one of our readers who asked if senescent macrophages (the cleaner cells of the body) should be the focus of senescent cell removal. Some research this year by Gudkov et al. suggests that macrophages become tainted by senescent cell signals and become dysfunctional and that removing them could be beneficial as they could be replaced with macrophages that do work properly.

Check out the campaign at Lifespan.io and donate to a better healthier future:

Continue reading “CellAge Campaign Q&A: Are Senescent Macrophages The Problem Or Other Cell Types?” | >

Amazon has designed a floating warehouse that sits thousands of feet in the air, from which the internet retailer could dispatch swarms of delivery drones to metropolitan areas.

The company has patented futuristic plans for enormous “airborne fulfillment centres” that would be used as bases for aerial deliveries to homes.

Flying at up to 45,000 feet, the warehouses would be suspended by cables from zeppelin-style airships, and stocked with popular items. When a shopper makes an order, an onboard drone would dive down to earth and deliver it, before being sent back up to the station by a shuttle that could also restock and refuel the floating warehouse.

Read more

Nice.

(NaturalNews) A diagnosis of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, was once considered a death sentence, but advanced automation technology is offering new hope to sufferers of the rare condition.

Most ALS patients eventually face an extremely difficult choice: either die from the lack of ability to breathe once the disease progresses or undergo a tracheostomy and spend the rest of one’s life on a ventilator – unable to move or speak.

Less than 10 percent of ALS patients choose the second option, but one man who suffers from the disease is helping to develop a viable third option: an opportunity to lead a relatively independent and mobile existence with the help of automation technology that can respond to head and eye movements, or even brain waves.

Read more

A man with deadly brain cancer that had spread to his spine saw his tumors shrink and, for a time, completely vanish after a novel treatment to help his immune system attack his disease — another first in this promising field.

The type of immunotherapy that 50-year-old Richard Grady received already has helped some people with blood cancers such as leukemia. But the way he was given it is new, and may allow its use not just for brain tumors but also other cancers that can spread, such as breast and lung.

Grady was the first person to get the treatment dripped through a tube into a space in the brain where spinal fluid is made, sending it down the path the cancer traveled to his spine.

Read more